WILMINGTON, N.C., Jan. 8, 2010 (GLOBE NEWSWIRE) — TranS1 Inc. (Nasdaq:TSON) announced today that Richard Randall, Chief Executive Officer, is scheduled to present at the J.P. Morgan Healthcare Conference in San Francisco on Thursday, January 14, 2010 at 11:00 a.m. PT. Mr. Randall will provide an overview of the Company and an update on its proprietary minimally invasive surgical approach to treat degenerative disc disease and instability affecting the lower lumbar region of the spine.
The presentation will be webcast live and may be accessed by visiting TranS1’s website at http://www.trans1.com. A replay of the webcast will also be available immediately after the conclusion of the presentation. Investors can access the webcast under the investor relations section of TranS1’s website.
About TranS1 Inc.
TranS1 is a medical device company focused on designing, developing and marketing products that implement its proprietary minimally invasive surgical approach to treat degenerative disc disease and instability affecting the lower lumbar region of the spine. TranS1 currently markets two single-level fusion products, the AxiaLIF(R) and the AxiaLIF 360(TM), and a two-level fusion product, the AxiaLIF 2L(TM), in the US and Europe. TranS1 was founded in May 2000 and is headquartered in Wilmington, North Carolina. For more information, visit www.trans1.com.
CONTACT: TranS1 Inc.
Investors:
Michael Luetkemeyer, Chief Financial Officer
910-332-1700
Westwicke Partners
Mark Klausner
443-213-0501
mark.klausner@westwicke.com
